At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 16 enrolled
Drug / intervention
Verapamil +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Relative Bioavailability of BI 10773 Given Alone and Together With Verapamil - an Open-label, Randomised, Crossover Trial in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating Verapamil and BI 10773 for Healthy. Completed, enrolled 16 participants across 1 site.
Detailed Summary
Relative bioavailability of BI 10773 given alone and together with verapamil
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedJan 2011
Primary CompletionFeb 2011
TodayJul 2026
First PostedJan 13, 2011
Enrollment StartJan 1, 2011
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 15.5 years ago
Interventions
Verapamildrug
single dose verapamil
BI 10773drug
single dose BI 10773
BI 10773drug
single dose BI 10773